Search





Search





Markets
/
Stocks
/
sva
/

Sinovac Biotech Ltd

SVA

Add to Watchlist

0.0000.00%

Close 12-22 16:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM

Sinovac Biotech Ltd

0.0000.00%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

SVA Financials

See Sinovac Biotech Ltd's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Sinovac Biotech Ltd Earnings Date

Latest Release

Jun 5, 2026

EPS / Forecast

-0.83/--

Revenue / Forecast

386.01M/--

See Upcoming Earnings >>

Period

FY2025 Earnings

Revenue(YoY)

386.01M

EPS(YoY)

-0.83

Analyst Rating

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2024H1

FY2023H2

FY2023H1

FY2022H2

FY2022H1

FY2021H2

FY2021H1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q3

FY2018H2

FY2018Q2

FY2018H1

FY2018Q1

FY2017H2

FY2017H1

FY2016Q4

Financial Indicators

EPS

---0.11

----

Revenue

-13.58%121.34M

9.77%307.87M

-88.42%140.40M

-96.66%280.47M

-88.96%1.21B

--8.39B

--10.98B

303.71%327.45M

79.43%115.45M

-18.30%52.33M

-57.90%15.39M

--81.11M

19.27%64.34M

-14.78%64.05M

-22.78%36.55M

--53.95M

-0.26%107.16M

--75.15M

83.07%122.49M

--47.34M

----

Net Profit

-177.88%-10.87M

67.92%-119.86M

-97.10%13.96M

-111.13%-373.67M

-90.57%481.55M

--3.36B

--5.11B

394.94%107.32M

53.60%9.65M

-149.33%-5.26M

-722.95%-7.36M

--21.68M

-29.11%6.28M

86.11%10.65M

-85.87%1.18M

--8.86M

-48.53%7.70M

--5.72M

29.78%14.09M

--8.36M

----

Net Margin

---56.57%

----

Gross Margin

--66.35%

----

Debt to assets ratio

--2.40%

----

Income Statement

Revenue

-13.58%121.34M

9.77%307.87M

-88.42%140.40M

-96.66%280.47M

-88.96%1.21B

--8.39B

--10.98B

303.71%327.45M

79.43%115.45M

-18.30%52.33M

-57.90%15.39M

--81.11M

19.27%64.34M

-14.78%64.05M

-22.78%36.55M

--53.95M

-0.26%107.16M

--75.15M

83.07%122.49M

--47.34M

----

Operating profit

37.70%-268.19M

91.29%-93.82M

-169.79%-430.48M

-114.52%-1.08B

-93.91%616.86M

--7.42B

--10.13B

582.56%197.04M

99.22%27.78M

-100.84%-178.00K

-277.34%-8.83M

--28.87M

-14.92%13.94M

52.51%21.07M

-66.69%4.98M

--16.39M

-48.41%16.67M

--13.81M

118.40%28.72M

--14.94M

----

Net Profit

-177.88%-10.87M

67.92%-119.86M

-97.10%13.96M

-111.13%-373.67M

-90.57%481.55M

--3.36B

--5.11B

394.94%107.32M

53.60%9.65M

-149.33%-5.26M

-722.95%-7.36M

--21.68M

-29.11%6.28M

86.11%10.65M

-85.87%1.18M

--8.86M

-48.53%7.70M

--5.72M

29.78%14.09M

--8.36M

----

Balance Sheet

Current assets

-5.27%11.15B

-2.44%11.83B

-10.26%11.77B

-18.70%12.13B

12.20%13.12B

--14.92B

--11.69B

346.30%1.56B

35.55%424.77M

11.26%338.00M

16.29%329.35M

--349.61M

--313.36M

--303.79M

--283.22M

----

39.38%284.18M

----

31.19%213.06M

----

--203.89M

--162.41M

1.75%130.75M

Total current liabilities

-17.75%978.45M

5.15%1.15B

110.61%1.19B

-54.76%1.09B

-82.92%564.86M

--2.41B

--3.31B

679.38%679.61M

161.03%193.86M

62.59%113.52M

43.75%81.29M

--87.20M

--74.27M

--69.82M

--56.55M

----

-37.10%58.20M

----

7.62%83.80M

----

--92.54M

--77.86M

13.98%66.26M

Total assets

-6.03%12.90B

-3.23%13.66B

-8.90%13.73B

-15.72%14.11B

19.31%15.07B

--16.75B

--12.63B

320.37%1.90B

60.37%658.55M

31.09%529.37M

13.48%433.32M

--452.30M

--410.65M

--403.83M

--381.85M

----

23.58%369.78M

----

25.36%307.67M

----

--299.22M

--245.43M

4.15%211.35M

Total liabilities

-6.57%1.39B

16.64%1.64B

53.07%1.49B

-51.19%1.40B

-72.21%971.93M

--2.87B

--3.50B

680.39%781.20M

190.06%281.31M

107.94%191.38M

15.04%93.83M

--100.10M

--96.98M

--92.04M

--81.56M

----

-36.23%77.85M

----

15.30%110.54M

----

--122.08M

--95.87M

22.98%81.69M

Total equity

-5.97%11.51B

-5.43%12.02B

-13.17%12.24B

-8.38%12.71B

54.37%14.09B

--13.88B

--9.13B

218.04%1.12B

20.27%377.25M

8.40%337.99M

13.06%339.50M

--352.19M

--313.67M

--311.79M

--300.29M

----

64.80%291.93M

----

31.81%197.13M

----

--177.14M

--149.55M

-5.01%129.67M

Cash Flow Statement

Net operating income

-997.49%-438.90M

284.78%143.99M

95.05%-39.99M

-99.40%37.42M

-108.89%-808.17M

--6.27B

--9.09B

1718.88%481.10M

21.48%14.10M

-75.76%2.36M

-109.61%-18.24M

--26.45M

-11.75%11.61M

222.43%9.72M

-75.32%-8.70M

--13.15M

-64.76%19.26M

---7.94M

-322.20%-11.32M

---4.96M

----

Net investment

116.00%436.83M

91.12%-193.17M

23.82%-2.73B

-965.81%-2.18B

-9.46%-3.58B

--251.31M

---3.27B

-371.11%-152.15M

-694.38%-30.39M

-728.83%-47.87M

4705.39%25.65M

---32.30M

81.40%-3.83M

-338.57%-5.78M

63.88%-557.00K

---20.56M

-336.86%-22.40M

---1.32M

57.76%-2.86M

---1.54M

----

Net financing

-178.83%-171.18M

-15.85%-293.23M

1755.94%217.16M

86.44%-253.10M

139.01%11.70M

---1.87B

---30.00M

19574.68%541.64M

52284.09%23.05M

24872.94%21.23M

680.44%6.65M

--2.75M

-99.95%44.00K

102.81%85.00K

82.52%-1.15M

--85.64M

1258.99%72.14M

---3.02M

-19.62%-7.96M

---6.55M

----

FAQs

What is the total revenue of Sinovac Biotech Ltd?



According to Sinovac Biotech Ltd's FY2025 earnings report, its total revenue reached 386.01M, with a year-on-year change of 386.01M.